Fig. 3From: Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic gliomaMAPK pathway activation is a positive predictive marker. BRAFV600E in the absence of H3K27M in low grade tumours. a shows a survival advantage. BRAF fusion events in low grade tumours. b shows robust survival. MAPK activation combined. c shows reveals a positive prognosis throughout low and high grade tumoursBack to article page